Journal
BIOLOGICAL PROCEDURES ONLINE
Volume 23, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12575-021-00158-4
Keywords
Rheumatoid arthritis; Exosome; Autoimmune diseases; Therapy
Categories
Ask authors/readers for more resources
Auto-immune diseases affect a significant portion of the population in wealthy countries, with Rheumatoid Arthritis being a common autoimmune disease. This condition can lead to synovial inflammation and joint injury, and exosomes have emerged as potential therapeutic vectors for treating such diseases.
Auto-immune diseases involved at least 25% of the population in wealthy countries. Several factors including genetic, epigenetic, and environmental elements are implicated in development of Rheumatoid Arthritis as an autoimmune disease. Autoantibodies cause synovial inflammation and arthritis, if left untreated or being under continual external stimulation, could result in chronic inflammation, joint injury, and disability. T- and B-cells, signaling molecules, proinflammatory mediators, and synovium-specific targets are among the new therapeutic targets. Exosomes could be employed as therapeutic vectors in the treatment of autoimmune diseases. Herein, the role of cell organelle particularly exosomes in Rheumatoid Arthritis had discussed and some therapeutic applications of exosome highlighted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available